Details
| Stereochemistry | MIXED |
| Molecular Formula | C33H40I6N6O15 |
| Molecular Weight | 1522.1287 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OCC(O)CNC(=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(N(CC(O)CN(C=O)C2=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C2I)C=O)=C1I
InChI
InChIKey=BFVVDRUCXCIALU-UHFFFAOYSA-N
InChI=1S/C33H40I6N6O15/c34-22-18(30(57)40-1-13(52)7-46)24(36)28(25(37)19(22)31(58)41-2-14(53)8-47)44(11-50)5-17(56)6-45(12-51)29-26(38)20(32(59)42-3-15(54)9-48)23(35)21(27(29)39)33(60)43-4-16(55)10-49/h11-17,46-49,52-56H,1-10H2,(H,40,57)(H,41,58)(H,42,59)(H,43,60)
Ioforminol is a triiodobenzenedicarboxamide derivative patented by Ge Healthcare A/S as diagnostic agent for X-ray imaging. The toxicity and biodistribution properties of Ioforminol are similar to those of other radiographic contrast media. However, the osmolality of Ioforminol solutions is considerably lower than that of other dimeric radiographic contrast media, thus allowing for an iso-osmolar formulation containing a high concentration of electrolytes. Ioforminol has been used in trials studying the diagnostic of Cardio Renal Safety in High-risk Elderly Subjects Undergoing a Coronary CATH
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01672996
Iopamidol 300 mgI/mL Given as a single administration to the subject
Route of Administration:
Intravenous
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9245
Created by
admin on Mon Mar 31 21:16:51 GMT 2025 , Edited by admin on Mon Mar 31 21:16:51 GMT 2025
|
PRIMARY | |||
|
DTXSID10649368
Created by
admin on Mon Mar 31 21:16:51 GMT 2025 , Edited by admin on Mon Mar 31 21:16:51 GMT 2025
|
PRIMARY | |||
|
25222171
Created by
admin on Mon Mar 31 21:16:51 GMT 2025 , Edited by admin on Mon Mar 31 21:16:51 GMT 2025
|
PRIMARY | |||
|
CHEMBL2219417
Created by
admin on Mon Mar 31 21:16:51 GMT 2025 , Edited by admin on Mon Mar 31 21:16:51 GMT 2025
|
PRIMARY | |||
|
1095110-48-7
Created by
admin on Mon Mar 31 21:16:51 GMT 2025 , Edited by admin on Mon Mar 31 21:16:51 GMT 2025
|
PRIMARY | |||
|
100000177677
Created by
admin on Mon Mar 31 21:16:51 GMT 2025 , Edited by admin on Mon Mar 31 21:16:51 GMT 2025
|
PRIMARY | |||
|
ZZ-126
Created by
admin on Mon Mar 31 21:16:51 GMT 2025 , Edited by admin on Mon Mar 31 21:16:51 GMT 2025
|
PRIMARY | |||
|
DB12439
Created by
admin on Mon Mar 31 21:16:51 GMT 2025 , Edited by admin on Mon Mar 31 21:16:51 GMT 2025
|
PRIMARY | |||
|
95FNF21CDN
Created by
admin on Mon Mar 31 21:16:51 GMT 2025 , Edited by admin on Mon Mar 31 21:16:51 GMT 2025
|
PRIMARY | |||
|
C175092
Created by
admin on Mon Mar 31 21:16:51 GMT 2025 , Edited by admin on Mon Mar 31 21:16:51 GMT 2025
|
PRIMARY |
ACTIVE MOIETY